COMPANY PROFILE

CND Life Sciences

Explore full profile

Develops an accurate, evidence-based tool that helps confirm a diagnosis of synucleinopathy

Phoenix, United StatesFounded 2017Health Tech & Medtech

Valuation $0–100M Latest valuation · 2025

Revenue $1–10M Latest reported FY

Headcount 100–500 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About CND Life Sciences

CND Life Sciences is a medical technology company that has developed the Syn-One Test, the first commercially available test to detect phosphorylated alpha-synuclein in skin biopsies. This aids in the diagnosis of synucleinopathies, a group of neurodegenerative diseases that includes Parkinson's disease and dementia with Lewy bodies.

Read full description

The company provides clinicians with a diagnostic tool that offers objective pathological evidence, which can be particularly valuable for diseases that are challenging to diagnose. The process involves a physician collecting three small skin biopsies from the patient using CND's Skin Biopsy Test Kit. These samples are then sent to CND's laboratory for analysis.

CND Life Sciences operates in the neurodiagnostics market, serving neurologists and other healthcare providers. The company's business model is based on the sale of its diagnostic test services. CND Life Sciences has secured funding to support its commercial expansion and further research, including a grant from The Michael J. Fox Foundation to study the quantification of pathological alpha-synuclein.

Source: Dealroom company data

At a glance

Status: Operational
Founded: 2017
Headquarters: Phoenix, United States
Employees: 143
Open positions: 1
Dealroom signal: 89.0/100
Industry: Health
Sub-industry: Health Platform
Sector: Health Tech & Medtech, Hard Tech
Business model: SaaS
Client focus: b2b
Links: Website LinkedIn X

Latest news

Press, funding announcements and product moves mentioning CND Life Sciences.

See all news

Funding history

9 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
EARLY VC✓Equity / VC	Aug 2026	$0	—	Curve Partners	↗
SERIES A✓Equity / VC	May 2025	$14M	$54M	VILAS Ventures	↗

Showing the latest 2 of 9 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

Year	Revenue	Growth
2026
2025
2024
2023
2022
2021		—

Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

CND Life Sciences website traffic

Latest recorded traffic for CND Life Sciences is 8.5K monthly website visits, up 25% over the last three months. CND Life Sciences's team grew 16.3% over the past year.

Latest monthly visits8.5K 3-month web change+25% 1-year team growth+16.3%

Monthly website visitsJan 2021–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom

Director, Product ManagementScottsdale, AZ · Project Management · Jul 10, 2026

1 distinct opening shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
AHAsenda HealthDisrupting the industry by building the only connected platform where the three pillars can collect, exchange, analyze and act on patient data in real-time	Houston, United States	Operational	1	$4.7M	$16M
MEMetreOperates as a metabolic health platform	New York City, United States	Operational
PPPro ParentsEmployer benefit platform for parents @work	Amsterdam, Netherlands	Operational
ATAllterum TherapeuticsAdvancing targeted therapies for IL-7R expressing cancers to transform patient outcomes	Houston, United States	Operational
BEBentoDental plan platform that connects organizations, employers, patients, and dentists directly without the need for traditional dental insurance companies	Boston, United States	Operational
BIBiocrineOffers a unique opportunity to study molecular processes within a living cell	Solna kommun, Sweden	Operational
SUSupergutPrebiotic fiber foods for metabolic and gut health	Los Angeles, United States	Operational
R-R-ZeroThe first biosafety technology company dedicated to making the indoor spaces we share safer, healthier and more productive	Salt Lake City, United States	Operational